The dawn phenomenon 6 November 2023 What is the dawn phenomenon? The dawn phenomenon is an early morning rise in blood glucose levels. It is due to a night time increase in certain hormones, which provides energy to help you wake. How common is it? Studies show that around half of all people living with type 1 or type 2 diabetes experience it. How do you know you have it? The main sign is an elevated glucose level in the early morning usually between 4am and 8am. You go to bed, your glucose level is 5mmol/L. When you wake, it is above this. How much higher depends on the individual. You may want to monitor between 2am and 6am, or on waking, to see if there is a rise. Causes Stress hormones, such as cortisol, glucagon, and adrenaline, are released overnight and your liver releases glucose into the system in response to these hormones. These hormones can also increase insulin resistance. Making it harder for insulin to do its job. In a person without diabetes there is no rise in the morning. This is due to the body being able to produce more insulin to counter the effects of the stress hormones. Those living with type 1 diabetes need to rely on previously injected insulin, which may not be enough. If not enough, it can lead to a rise in fasting blood glucose. Those living with type 2 diabetes, may not be able to produce the right amount of insulin to regulate the overnight glucose release and/or their insulin cannot do its job effectively. This may also lead to a rise in fasting blood glucose. Why do something about it? It is important to keep blood glucose in your individualised target range to prevent damage to blood vessels and nerves. This reduces your risks of diabetes-related complications. The general fasting blood glucose target range, for those who have type1 or type 2 diabetes, is between 4 and 7mmol/L. Do note your doctor may set your target at a different level. For more information see the NDSS blood glucose monitoring fact sheet. Treatment and prevention It takes effort to deal with elevated fasting glucose levels. Reach out to your diabetes team to discuss some of the following options: Reviewing your insulin – need, type, dose, and timing. If you use an insulin pump, you can consider setting the insulin rates to vary overnight, giving more insulin when glucose is released. Another option is using a hybrid closed-loop insulin delivery system. This is where you wear a continuous glucose monitor which feeds glucose data to your insulin pump. The pump adjusts your night time background insulin rates automatically. It is an excellent way to keep your blood glucose in target range over night. Adjusting oral medication, type, dosage, and timing. Eating enough carbohydrate for your needs during daytime hours and avoiding snacking before bedtime. Maintaining healthy fat levels in your body and reducing your insulin resistance. Being physically active to increase insulin sensitivity. Walking, or working out, after dinner may reduce your overnight and fasting glucose levels. Exercising in the morning, to use up the extra glucose. For guidelines, see the NDSS Physical activity factsheet. Remember when changing your activity levels, especially before bedtime, it is best to monitor your glucose levels. You could be at risk of having low glucose levels, known as hypoglycaemia (hypo). Discuss how to prevent and treat hypoglycaemia with your diabetes care team. If you have any general questions around the dawn phenomenon or glucose levels, call the NDSS help line on 1800 637 700. You can receive a call back and speak with a credentialled diabetes educator, accredited practicing dietitian or accredited exercise physiologist. By Monica McDaniel-Wong, Credentialled Diabetes Educator
Media releases 22 November 2023 Regional and remote Australians urged to get late flu vaccine People living with diabetes in rural and remote areas are being urged to get their flu shot now after low rates of flu vaccinations have put communities at risk across Australia this year. Continue Reading
Media releases 15 November 2023 New diabetes research announced – DKA Professor Tony Russell, a leading endocrinologist and president of the Australian Diabetes Society, is a recipient of this year’s Diabetes Australia Research Program’s (DARP) Millenium Award for a multicentre trial into the treatment of diabetic ketoacidosis (DKA), a little-known but potentially fatal complication of diabetes. Continue Reading
News 10 November 2023 ‘Green lane’ for people with diabetes to navigate airport security Some Australians living with diabetes are experiencing distress getting through airport security screening, so Diabetes Australia is taking action to educate workers and improve the experience for people living with diabetes. Continue Reading